Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04238143 · ClinicalTrials.gov registry record · NA

Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis

A NA study of Osteoarthritis and Osteoarthritis, Knee, sponsored by Healeon Medical.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
2
Study locations

NCT04238143: Recruiting NA study of Osteoarthritis and Osteoarthritis, Knee, sponsored by Healeon Medical.

NCT04238143 is a NA study of Osteoarthritis and Osteoarthritis, Knee that is actively recruiting participants, run by Healeon Medical. The registered enrollment target is 100 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04238143, a NA study of Osteoarthritis and Osteoarthritis, Knee, is actively recruiting participants, sponsored by Healeon Medical.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical interventions have not yielded convincing long-term outcomes, including total joint replacement surgeries and medical management of the supportive structures. This study is to use a person's own stem/stromal Cells (autologous) plus HD-PRP (important healing growth factors and signal molecules) in such cases of OA for long-term minimally invasive treatments. Baseline (existing) findings are documented, and thence tracked as to progress deemed to be result of the intervention.

Primary Outcome

Adverse and Severe Adverse Events

Conditions Studied

Osteoarthritis Osteoarthritis, Knee Osteoarthritis, Hip Osteo Arthritis Shoulders Osteoarthritis of Multiple Joints Osteoarthritis - Ankle/Foot

Interventions

  • PROCEDURE Tissue Stromal Vascular Fraction (tSVF) Arm 1
  • BIOLOGICAL PRP Concentrate Arm 1
  • PROCEDURE Tissue Stromal Vascular Fraction (tSVF) Arm 2
  • BIOLOGICAL PRP Concentrate Arm 2
  • PROCEDURE Cellular Stromal Vascular Fraction (cSVF) Arm 2

Study Locations (2)

California

  • Hemwall Center for Orthopedic Regenerative Medicine - Valencia

Montana

  • Regenevita LLC - Stevensville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-01-10
Est. Completion 2027-09-30
Phase NA
Healeon Medical

1 total trials

What NCT04238143 shows while recruiting

NCT04238143 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (88% lower).

The record links to 6 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 5 interventions - of which Tissue Stromal Vascular Fraction (tSVF) Arm 1 is the first listed.

NCT04238143 reports a single indexed study location in California, Montana.

Frequently Asked Questions

What is clinical trial NCT04238143 about?

NCT04238143 is a clinical study titled "Adipose-Derived Biocellular Regenerative Therapy for Osteoarthritis". Use of Biocellular and cellular approaches to treatment of Osteoarthritis (OA), musculoskeletal aging processes, pain, and degenerative changes are to be studied with minimally invasive protocols, and non-pharmaceutical means to relieve OA and its associated issues. Traditional surgical intervention...

What is the current status of trial NCT04238143?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2020-01-10. Estimated completion is 2027-09-30.

What conditions does trial NCT04238143 study?

This clinical trial studies the following conditions: Osteoarthritis, Osteoarthritis, Knee, Osteoarthritis, Hip, Osteo Arthritis Shoulders, Osteoarthritis of Multiple Joints.

What interventions are being tested in trial NCT04238143?

The interventions under investigation include: Tissue Stromal Vascular Fraction (tSVF) Arm 1 (PROCEDURE), PRP Concentrate Arm 1 (BIOLOGICAL), Tissue Stromal Vascular Fraction (tSVF) Arm 2 (PROCEDURE), PRP Concentrate Arm 2 (BIOLOGICAL), Cellular Stromal Vascular Fraction (cSVF) Arm 2 (PROCEDURE).

Who is sponsoring clinical trial NCT04238143?

This trial is sponsored by Healeon Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04238143 being conducted?

This trial has 2 study locations across California, Montana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04238143's enrollment target sits among peer trials

100 88th of 135 higher than 45 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT04238143

Source: ClinicalTrials.gov NCT04238143, the US trial registry maintained by the National Library of Medicine. NCT04238143 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.